| 000 | 01108 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250518011024.0 | ||
| 264 | 0 | _c20190306 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/s12885-018-5076-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarcath, Lauren A | |
| 245 | 0 | 0 |
_aPrevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials. _h[electronic resource] |
| 260 |
_bBMC cancer _cNov 2018 |
||
| 300 |
_a1155 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedical Oncology |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPrevalence |
| 700 | 1 | _aCoe, Taylor D | |
| 700 | 1 | _aHoylman, Emily K | |
| 700 | 1 | _aRedman, Bruce G | |
| 700 | 1 | _aHertz, Daniel L | |
| 773 | 0 |
_tBMC cancer _gvol. 18 _gno. 1 _gp. 1155 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12885-018-5076-0 _zAvailable from publisher's website |
| 999 |
_c29080942 _d29080942 |
||